Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Exactly. Progress is being made behind the scene.
If you are determing that by looking on OTC Markets, we need to now wait for OTC Markets to update that status based on the recent filings.
It is right there on page 1.
There are check boxes indicating the status.
Vince said "thousands of deals" would be on 4.0 when it launched (Tweet from July). What a disappointment so far.
That Attorney is very popular with custodian cases. Have seen his name many times on other custodial cases.
I am thinking he has a silent partner also.
Has anyone heard if there were plans to make a phone app version of YSO?
Endonovo Announces Distribution Agreement with Academy Medical
March 06, 2023 09:07 ET
Provide Improved Medical Services to VHA and U.S. Dept. of Defense
Los Angeles, CA, March 06, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced the signing of a Service-Disabled Veteran-Owned Small Business (SDVOSB) Government Reseller Agreement (Agreement or Contract) with Academy Medical, Inc. of West Palm Beach, FL to distribute SofPulse® medical devices to ensure its availability to the Veterans Health Administration (VHA) and Department of Defense (DoD) contracts.
The new Contract allows Academy Medical and Endonovo to team up and bring top-notch medical and surgical supplies, as well as telehealth solutions, to our military and veterans.
SofPulse® Benefits for Veterans
SofPulse® Pulse Electro Magnetic Frequency (PEMF) medical devices are FDA cleared and clinically proven for the reduction of postoperative pain and edema. Endonovo’s Medical Device Division, run by Ira Weisberg President and Chief Commercial Officer, is focusing on commercializing its SofPulse® medical device line and telehealth initiatives. Weisberg has a proven track record of growing revenues and demand for similar medical device companies. Through the announced Agreement, he is expected to have similar success developing distribution for SofPulse®. This newly-signed Agreement with Academy Medical is designed to improve healthcare for both our military and veterans, better access to medical and surgical supplies and telehealth solutions that make a real impact in the lives of our heroes.
The Agreement
The Agreement with Endonovo focuses on developing commercialization initiatives to improve the post-operative outcomes of our military and veterans by reducing pain and edema while improving recovery times and reducing opioid use after surgery.
Additionally, this Agreement allows Academy Medical to provide its expertise in the procurement process of medical and surgical supplies to enhance access to the federal medical marketplace and the distribution of SofPulse®. The result of the Agreement will offer improved access to medical and surgical supplies for veterans as well as offering veterans a non-opioid solution for postoperative pain management.
Weisberg said of the announcement: “Teaming up with Academy Medical is an important step in SofPulse, Inc.’s growth and expansion. Academy Medical’s federal contracts and networks are active in every region of the world. Together we plan to bring better medical solutions to veterans and their families and provide improved access to medical and surgical supplies on a global level."
Expanded Distribution of SofPulse®
Academy Medical holds several Indefinite Delivery, Indefinite Quantity (IDIQ) contracts and Blanket Purchase Agreements (BPAs). It offers over 45,000 products from over 30 supplier partners to the Department of Defense and other federal agencies with the VHA as its largest customer.
"Academy Medical is proud to partner with Endonovo’s SofPulse® and bring our expertise in the federal procurement process to this exciting partnership," said John Campbell, Vice President/Government Affairs from Academy Medical. "We are committed to improving the health, well-being and quality of life of veterans and service members, and this partnership will allow us to do just that."
Teaming up with SofPulse® is expected to bring enhanced benefits to veterans including: improved access to medical and surgical supplies, reduction of opioid use postoperatively and improved recovery times allowing our military and veterans to get back to their lives faster. It also has the potential to drive growth and expansion for both Academy Medical and Endonovo as they work together to provide better medical solutions to veterans.
Endonovo Moves on From VHSS
With the announcement of the partnership with Academy Medical, Endonovo terminated its previous contract with Veterans Healthcare Supply Solutions Inc. (VHSS).
Weisberg commented on the change: “Academy Medical offers expanded services and contracts not previously available through our past VA contract. The new Agreement allows SofPulse, Inc. to expand exponentially by being listed with Academy Medical’s Dept. of Defense and VHA contracts. We appreciate VHSS services, but as we move forward and expand distribution throughout the federal marketplace, Academy Medical is the partner we see as giving us the best opportunity to succeed in our expansion.”
About Academy Medical
Academy Medical, Inc. is a Service-Disabled Veteran-Owned Small Business (SDVOSB) that improves the health, well-being and quality of life of Veterans and service members by making the complex procurement process easier for its federal agency customers and supplier partners. Academy Medical is an SDVOSB comprised of combat veterans led by Naval Academy and West Point graduates together with a 1/75 Army Ranger, a Marine Corps Heavy Machine Gunner and other patriotic employees. Academy Medical entered the government market with its first FSS contract in 2010 for the provision of medical and surgical supplies to the U.S. Department of Veterans Affairs (VA) and has been solely in the federal medical marketplace for 12 years. Today, the company holds several IDIQ contracts and BPAs and offers over 45,000 products from over 30 supplier partners to the Department of Defense and other federal agencies with the VA as its largest customer. Academy Medical is headquartered in West Palm Beach, Florida. Learn more about partnering with the company in its service-driven business at www.academymedical.net.
Maybe they can answer what happened to this quote about their CBD business. LOL.
"Conservatively speaking, we are projecting average “blended” gross profits in excess of $18.5 million annually over the next five years.“
But they are filing quarterly and annual earnings reports.
What was his reply?
I was also shocked by the lack of deals in major cities in Florida.
Nothing shows up for Miami, Jacksonville, Daytona, Naples and Tampa. Zero results.
I thought Joe, living in Naples, would have had some local companies registered at least in his own city.
Perhaps they are first working on national chains?
We have seen and learned by now...speed is not in the vocabulary of PNNX...<grin>
They were going to increase the Authorized Shares. One can only hope that will be due to a merger of some sort and will be mostly for restricted shares and not for shares in the float.
We can only continue to sit hear and wait to hear something from the company. I have not heard of anyone being able to get responses to questions lately. They seemed to be tight lipped.
Looks like today's selloff is confirmation this is expected to go to Expert Market.
No change in share structure is good news.
You had me excited for a moment. Thought a new PR had been issued.
Endonovo Announces Q&A with Newly-Appointed SofPulse Medical Division President, Ira Weisberg
Los Angeles, CA, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV), a medical device company specializing in pulsed electromagnetic field (PEMF) technology, announced today it will hold a question and answer session for shareholders on March 9, 2023 at 4:30pm EST with Ira Weisberg, President of Endonovo’s Medical Division.
The meeting and dialogue with shareholders will be virtual and accessible through the following ZOOM link: https://us02web.zoom.us/j/86916857785?pwd=VG5RRjlDSjJ0eTg3TFRpejFuN1M2Zz09.
Weisberg will present detailed current and future Company plans, including updates on new products and marketing initiatives, especially focused on its proprietary SofPulse® PEMF technology medical devices, that are opioid-free and FDA cleared to reduce post-surgical pain and edema. SofPulse® devices have shown significant clinical results and ongoing benefits in accelerating healing and recovery in a range of medical applications, including orthopedics, sports medicine, general surgery, plastic surgery, pain management and wound care.
Many Questions Have Already Been Submitted Relating to:
Specifics on the SofPulse® path for greater growth and innovation;
How Weisberg’s 25 years of experienced leadership and contacts in the medical device field bear on the future expansion of SofPulse® PEMF technology;
Update on how the market evaluation is being conducted by Ocean Tomo;
Progress on the planned spin-off of SofPulse® technology from Endonovo into the newly- formed SofPulse Inc.;
Future plans for SofPulse Health™, its telehealth initiative as well as international and veterans market expansions.
In making the announcement, Weisberg said: "I am honored to join Endonovo as President of the Medical Device Division. The Company's PEMF technology has the potential to revolutionize the medical industry, and I am excited to lead the charge in bringing this technology to more patients and healthcare providers. I look forward to virtually meeting our shareholders and answering their questions regarding our current expansion and how we plan to make SofPulse® technology more available to consumers in the future."
Ongoing Business Expansion
Expansion initiatives created through Weisberg’s ongoing ‘Go to Market” campaign include:
New international contracts and developing market opportunities;
Contracts to significantly expand access to the U.S. Veterans Association and Department of Defense medical markets;
Development of telehealth platform for the distribution of category 2 prescription medical devices and direct-to-consumer category 1 non-prescription medical devices for both;
Development of future PEMF products to be released for the Over-the-Counter consumer market that will help bring the benefits of PEMF therapy to a global audience.
Good one. There will be some obstacles.
Everyone just needs to be patient and allow time for the attempts to clear them.
We can't be impatient like Donkey...asking if we are there yet. <grin>
It's going to be a long road of wait. We have the court case to wait on. Then the financials catchup. If I recall correctly, Omni/John had a difficult task in completing one of the financials during the time of the Chinese ownership. That was his holdup in getting this one current before the deadline of OTC reporting changes.
But at least those of us that continued to hold now have a potential light at the end of the tunnel of recouping some $$.
John Farley has absolutely nothing to do with the current AVVH business.
ZHUD - new custodian case for this shell.
https://www.clarkcountycourts.us/Portal/Case/CaseDetail?eid=UjdpGdQzh_ULUqEvp9k2PQ2&tabIndex=3
Interesting. Thanks for the update.
Belisarian Holdings, LLC is a new company. Let's see how they handle ZHUD with the great share structure it has.
Speaking of jail....Donnie Rudd passed away in jail in Sept 2022.
For such a dormant shell with hardly any trading activity, there are quite a few MMs on L2 now...some are dilutors.
Absolutely nothing.
Either dead money moving elsewhere or some dilution to pay some operating expense.
On the positive side....no changes.
Strange Bid/Ask on TDA.
Ask from TDA shows .065 but looking at L2, the first Ask is at .079.
Don't overlook the 5.7M at .002 also.
Here is the website for itouch since there are many references to itouch not related to the kiosk.
https://itouchorlando.com/how-it-works/
You are also assuming the Twitter account has been taken over. You have no verifiable evidence. Just because you have an assumption based on semantics does not make you right and everyone else wrong.
If it was hacked or taken over...i'm sure there would be a lot more activity from it.
Just because you believe it to be fake or hacked does not make it so.
Are you saying you only see 3.0.based on Google search result? Have you actually entered the site to see the page differences?
I have validated the legitimacy of the Twitter account.
Go to Gold Quest Capital website...the official website...and they specifically reference the Twitter account you claim to be fake. It is not fake.
Here is the link to the webpage.
https://goldquestcapital.com/avvaa-world-health-care-products-inc-announces-shareholder-update
I have seen my orders under those MMs on other transactions.
PAUL, VNDM, CFGN...are diluting MMs of which I don't see retail orders go under.
Ooops..you are correct. You just can't search for a specific post number.
Now I noticed the referenced post number by Old guy is very far from the current post numbers. Probably missing a digit.
FYI....Those that use the ihub app cannot see post #s.
I do not believe the company is dead.
They just recently released a quarterly financial report. That alone should tell you they are still operating. If this was dead or planning to kill it, they would not have released the most recent report.
They are being too quiet. I agree.
Does not mean they are doing nothing behind the scene.
Endonovo Retains Ocean Tomo, a Part of J.S. Held, to Provide Fairness Opinion Analysis for Medical Device Spin-Off
Los Angeles, CA, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) today announced the retention of Ocean Tomo, a part of J.S. Held, to conduct a fairness opinion analysis in connection with the proposed spin-off of Endonovo’s medical device assets to a newly formed Delaware company, SofPulse, Inc.
Endonovo’s SofPulse® medical device offers patients and healthcare providers significant benefits including a viable treatment solution for post-surgical pain, edema and edema reduction that works with effectiveness, convenience, innovation and quality. All products are supported with quality customer service.
Expert Opinion
“We are pleased to be engaged by Endonovo and look forward to working to provide the board with our assessment and conclusions,” said Ocean Tomo Managing Director Greg Campanella.
Ocean Tomo, a part of J.S. Held, is a leading provider of expert opinion, management consulting and advisory services focused on intellectual property (IP) and other intangible assets. Ocean Tomo has been retained to provide Endonovo with its opinion as to the fairness of the current Fair Market Value (FMV) and purchase price of Endonovo’s medical device operating segment.
The fairness opinion will be prepared for Endonovo and referenced in filings with the Securities and Exchange Commission (SEC). It will evaluate the fairness of the terms of the proposed spin-off from a financial point of view.
Assessment for Shareholders
Ocean Tomo, a part of J.S. Held, is a respected management consulting and financial services firm with deep expertise in the valuation of intellectual property, litigation and engineering. The firm has a proven track record of providing objective assessments of the fairness of transactions and has completed more than 1,000 engagements, including over 300 valuation and 500 financial damages expert testimony engagements.
Ocean Tomo’s analysis is expected to be completed in the first quarter of 2023. Once the proposed spin-off is fully structured and the necessary agreements are completed, Endonovo will prepare the appropriate filings with the SEC and provide information to shareholders.
Ocean Tomo’s Record
Ocean Tomo, a part of J.S. Held, has provided hundreds of objective assessments of the fairness of transactions. As a part of J.S. Held, Ocean Tomo works alongside more than 1,500 professionals globally and assists clients on complex technical, scientific and financial matters across all assets and value at risk.
Company services are built on more than three decades of experience in assessing intellectual property in rigorous venues. The firm's financial, market, scientific and technical experts have deep experience with tangible and intangible assets protected by intellectual property.
In retaining Ocean Tomo, Endonovo is demonstrating its commitment to acting in the best interests of their shareholders to provide a fairness opinion as an important step in the process of evaluating the Company.
It seems a simple call or email to Gold Quest can easily settle this Twitter profile debate.
On a side note, Cooley and Krisa Management Twitter profiles both follow the GQC Twitter profile. If anyone would know if it was fake, it would certainly be Cooley. Why would he follow a fake account? Unless it is some deception he is involved in himself.
I hope today is the start of the run. All buying volume!
Was wondering what created this volume today.
WORX needs a coordinated pump to get some volume. It had one by a group on Stocktwits early Dec.
Maybe they will come back for round 2 at this level.
Will the prescription requirement will be eliminated in the Direct To Consumer sales model?